Literature DB >> 15465762

Physiological concentrations of retinoic acid favor myeloid dendritic cell development over granulocyte development in cultures of bone marrow cells from mice.

Lindsy M Hengesbach1, Kathleen A Hoag.   

Abstract

Differentiation of hematopoietic progenitors to dendritic cells (DCs) is a complex, poorly understood process regulated by cytokines, colony-stimulating factors, growth factor receptors, and transcription factors. However, nutritional factors may play an important role. Vitamin A is essential for proper immune function and is implicated in the development of myeloid lineage cells, especially granulocytes. We investigated the role of vitamin A in the differentiation of myeloid DCs. Cultures of bone marrow cells from mice stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF) in medium with reduced serum retinol demonstrated significantly decreased DC development compared with control cultures containing retinol. Surprisingly, granulocytes predominated in cultures stimulated with GM-CSF when retinol was depleted. The addition of all-trans or 9-cis retinoic acid to cultures depleted of retinol significantly restored DCs and inhibited granulocyte development. The DC-promoting effect of vitamin A was specific to myeloid lineage development stimulated by GM-CSF because vitamin A significantly inhibited DC development stimulated by flt-3 ligand. Vitamin A also affected DC major histocompatibility complex (MHC) class II and costimulatory molecule expression. In response to increasing concentrations of vitamin A, the expression of MHC class II decreased on the DC, whereas the expression of costimulatory molecules increased, especially CD86. Our data suggest that vitamin A favors the differentiation of myeloid progenitors to immature myeloid DC instead of granulocytes when dietary vitamin A is adequate, and that vitamin A deficiency may compromise adaptive immune responses that depend on myeloid DC antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465762     DOI: 10.1093/jn/134.10.2653

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  31 in total

1.  Oral vitamin A and retinoic acid supplementation stimulates antibody production and splenic Stra6 expression in tetanus toxoid-immunized mice.

Authors:  Libo Tan; Amanda E Wray; A Catharine Ross
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

Review 2.  Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2005-07-27       Impact factor: 6.968

Review 3.  Stromal-dependent tumor promotion by MIF family members.

Authors:  Robert A Mitchell; Kavitha Yaddanapudi
Journal:  Cell Signal       Date:  2014-09-30       Impact factor: 4.315

4.  Vitamin A deficiency alters splenic dendritic cell subsets and increases CD8(+)Gr-1(+) memory T lymphocytes in C57BL/6J mice.

Authors:  David M Duriancik; Kathleen A Hoag
Journal:  Cell Immunol       Date:  2010-08-24       Impact factor: 4.868

5.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 6.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

7.  TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.

Authors:  Padmini Jayaraman; Falguni Parikh; Jared M Newton; Aurelie Hanoteau; Charlotte Rivas; Rosemarie Krupar; Kimal Rajapakshe; Ravi Pathak; Kavin Kanthaswamy; Cassie MacLaren; Shixia Huang; Cristian Coarfa; Chad Spanos; Dean P Edwards; Robin Parihar; Andrew G Sikora
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

Review 8.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26

9.  Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.

Authors:  Mitri Khoury; Geok Choo Sim; Michiko Harao; Laszlo Radvanyi; Behrang Amini; Robert S Benjamin; Peter W T Pisters; Raphael E Pollock; William W Tseng
Journal:  BMJ Case Rep       Date:  2015-07-08

10.  Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.

Authors:  Linda Hammerich; Frank Tacke
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.